Eritrea vs Senegal: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Eritrea
0.5%
in 2024
Senegal
0.4%
in 2024
Eritrea rank
56th
Senegal rank
59th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Eritrea
- Senegal
How they compare
Eritrea currently reports 0.5% against 0.4% in Senegal, a difference of 0.1%.
That makes Eritrea's figure about 1.2 times Senegal's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Senegal ahead.
Eritrea ranks 56th and Senegal ranks 59th of 215 countries.
Across the 2 decades both report, Eritrea averaged higher in 1 and Senegal in 1.
Head to head by decade
| Decade | Eritrea | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.6% | 0.8% | 0.2% | Senegal |
| 2020s | 0.6% | 0.5% | 0.1% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Eritrea or Senegal?
- Eritrea, at 0.5% against 0.4% in Senegal as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Eritrea and Senegal?
- 0.1%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Senegal?
- 10 years are reported by both, from 2015 to 2024.
- How do Eritrea and Senegal rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Eritrea ranks 56th and Senegal ranks 59th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.